Global - Adult Vaccines Market, Company Analysis and Forecast to 2021

Tuesday, November 8, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 7, 2016 /PRNewswire/ -- The adult vaccines market has been forecasted to increase at a compound annual growth

rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related
complications in the elderly. Adult vaccines continue to be one of the growing segment for pharmaceutical companies. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.

Adult Vaccines Market - Disease Wise AnalysisThe influenza vaccines capture maximum share of the total adult vaccines market. It is the most popular and accepted vaccination amongst adults. The hepatitis vaccines account for second highest share of the total adult vaccines market in 2015. The HPV/cervical cancer vaccines and pneumococcal vaccines captures the third and fourth highest share of the adult vaccines market respectively in 2015. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.Adult Vaccines Market - Company AnalysisNote: Novartis divested its non-influenza vaccine business to GlaxoSmithKline (GSK) and CSL acquired Novartis influenza vaccines business. In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second position in the adult vaccines market landscape. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer stands at the fourth spot in the adult vaccines market landscape.Adult Vaccines Market - Disease Wise Company Sales AnalysisGSK generates maximum adult vaccines sales from Hepatitis and DTP vaccines, while Sanofi Pasteur remains focused on maintaining its leadership in the influenza vaccines market. The cervical cancer and zoster shingles vaccines contributes maximum share of the total Merck adult vaccines sales. Novartis main source of adult vaccines sales revenue is the influenza vaccines.In 2011, Sanofi Pasteur replaced GSK and became the dominant player in the influenza vaccines landscape, while in the cervical cancer vaccines market, Merck is at the forefront and is expected to maintain its dominancy over a longer period of time. GSK is the clear leader in hepatitis vaccines market.

Adult Vaccines Market - Regional DistributionOn a regional basis, the United States comprises the single largest market for adult vaccines being closely followed by Europe. Japan's adult vaccines market share is expected to remain flat during the forecasting period, while China's adult vaccines market is likely to show continuous growth. South America and India are competing closely with each other to grab maximum share of the adult vaccines market pie. This is the 2nd edition report on Adult Vaccines Market by iGATE RESEARCH. The report titled "Global - Adult Vaccines Market, Company Analysis and Forecast to 2021" is a 239 Page report with 141 Figures and 12 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape. The 9 Diseases covered in the report are analyzed from four viewpoints:1. Adult Vaccines Market (2007 - 2021) 2. Number of Adults Vaccinated (2007 - 2021)3. Number of Doses (2007 - 2021) 4. Company Sales Share (2010 - 2021)The 7 Companies covered in the report are analyzed from two viewpoints:1. Disease Wise - Adult Vaccines Sales (2007 - 2021) 2. Strategic AlliancesThe 8 Region covered in the report are analyzed from one viewpoint:1. Adult Vaccines Market (2011 - 2021)Global Adult Vaccines Market, Number of Adults Vaccinated and Doses - Disease Wise Analysis to 2021 (9 Disease Analysed)1. Influenza2. Cervical Cancer3. Zoster Shingles4. Pneumococcal5. Meningococcal6. MMRV7. Hepatitis8. DTP9. Travel and MiscellaneousGlobal Adult Vaccines Market - Company Analysis to 2021 (7 Companies Analysed)1. GlaxoSmithKline2. Sanofi Pasteur3. Merck4. Novartis5. Pfizer6. bioCSL (Seqirus)7. Protein Sciences8. Other CompaniesGlobal Adult Vaccines Market - Regional Distribution to 2021 (8 Region Analysed)1. United States2. North America/Caribbean3. South America4. Europe5. Japan6. India7. China8. Rest of the WorldData SourcesiGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.Research MethodologiesPrimary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.Download the full report: ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

To view the original version on PR Newswire, visit:

SOURCE ReportBuyer


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store